Key result
Endothelial cells and shear stress drive calcification over two days in a CAVD-on-a-chip model.
Why the study?
Calcific aortic valve disease accounts for significant heart disease and lacks targeted interventions, while early-stage disease involves extracellular matrix reorganization and oxidized low-density lipoprotein deposition.
A 3D CAVD-on-a-chip model demonstrates that the combination of shear stress, endothelial cells, and oxLDL drives early-stage aortic valve calcification markers, offering a platform for preclinical drug testing.
Offers a platform for preclinical CAVD drug testing; leaves open human translation from this Level 5 model.
Background Early-stage calcific aortic valve disease (CAVD) has been characterized by the infiltration of immune cells, reorganization of the extracellular matrix, and the deposition and oxidation of low-density lipoproteins (oxLDL). Worldwide studies have revealed that aortic valve disease accounts for up to 43% of patients exhibiting heart disease. Methods We utilized a CAVD-on-a-chip platform of the aortic valve fibrosa to assess the hypothesis that culture calcification will increase with endothelial cell presence, increased oxLDL concentration (25 μg/ml or 50 μg/ml), and shear stress (20 dyne/cm 2 ). CAVD chips consisted of collagen I hydrogels with porcine aortic valve interstitial cells embedded and porcine aortic valve endothelial cells seeded on top of the matrix for up to two days. Results Here, we demonstrate that the presence of endothelial cells and shear stress drives alkaline phosphatase activity, sulfated glycosaminoglycan production, and the formation of mono-, di-, and octa- calcium phosphates, and hydroxyapatites. Two-day dynamic cultures showed 3D cell-oxLDL interactions, leading to extracellular matrix remodeling and endothelial dysfunction. Discussion Given that CAVD has no targeted intervention, continued evolution of this CAVD-on-a-chip model sheds light on mechanisms in disease onset and can lead to significant contributions in preclinical drug development.
No takes yet. Share an insight, caveat, or question.
Mendoza-Seale et al. (2025) studied Calcific aortic valve disease (CAVD). Endothelial cell presence, increased oxLDL concentration, and shear stress was evaluated on Culture calcification (alkaline phosphatase activity, sulfated glycosaminoglycan production, and formation of calcium phosphates and hydroxyapatites). A CAVD-on-a-chip model demonstrated that endothelial cells and shear stress drive alkaline phosphatase activity, glycosaminoglycan production, and calcium phosphate formation over two days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: